Compounded GLP-1s Under Scrutiny: What the 2026 Safety Data Shows

A 2026 study found unexpected interactions when compounded tirzepatide is combined with B12 — raising fresh concerns about the safety of compounded GLP1 preparations. Stanford Medicine and the FDA are both raising alarms about quality control in the compounding pharmacy space.

For research use only. Not for human consumption.